Cargando…
Clozapine monitoring at a specialised psychiatric hospital: A retrospective chart review
BACKGROUND: Clozapine is the only Food and Drug Administration (FDA) and National Institute for Care and Excellence (NICE) approved drug for treatment-resistant schizophrenia (TRS). Its potentially life-threatening haematological side effects of neutropaenia and agranulocytosis mandate rigorous moni...
Autores principales: | Daniels, Michelle V., Ramlall, Suvira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AOSIS
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623633/ https://www.ncbi.nlm.nih.gov/pubmed/37928939 http://dx.doi.org/10.4102/sajpsychiatry.v29i0.2039 |
Ejemplares similares
-
Clozapine use at a specialised psychiatric hospital in Johannesburg
por: Ord, Katherine L., et al.
Publicado: (2023) -
COVID-19 infection at a psychiatric hospital in KwaZulu-Natal, South Africa: Clinical service planning and challenges
por: Paruk, Saeeda, et al.
Publicado: (2022) -
Lurasidone Augmentation of Clozapine in Schizophrenia—Retrospective Chart Review
por: Siwek, Marcin, et al.
Publicado: (2023) -
Depression, anxiety and stress symptoms in patients presenting with dyspepsia at a regional hospital in KwaZulu-Natal province
por: Tshabalala, Sijabulisiwe J., et al.
Publicado: (2019) -
Subjective and objective cognition 6-week post-coronary artery bypass graft surgery: A descriptive pilot study
por: Ngcobo, Ntokozo N., et al.
Publicado: (2020)